24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Characterization of different G protein coupling properties of CB 1 and CB 2 cannabinoid receptors and GPR55 receptor using BRET

      abstract
      1 , 1 , 1 ,
      BMC Pharmacology
      BioMed Central
      15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Joint meeting with the Hungarian Society of Experimental and Clinical Pharmacology (MFT) and the Slovenian Pharmacological Society (SDF)
      19–21 November 2009

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background CB1 and CB2 cannabinoid receptors are G protein-coupled receptors which have been described to couple mainly to the Gi/o subfamily of G proteins. However, in some cell types and upon stimulation with certain cannabinoid agonists, activation of other G protein subtypes has also been observed. GPR55 is an orphan G protein-coupled receptor which has been suggested to be a novel member of the cannabinoid receptor family. Methods In this study we wanted to characterize the G protein activation properties of the two known cannabinoid receptors and GPR55 following stimulation with different cannabinoid ligands, using bioluminescence resonance energy transfer (BRET). We monitored the activation of different G protein subtypes (Go, Gq, Gs or G12) using Renilla luciferase-tagged wild type or chimeric Gαo subunits (i.e. Gαo with the C-terminal 5 amino acids replaced with those of Gαq, Gαs or Gα12, respectively) co-expressed with EYFP-tagged α1α11 subunit and the receptor in CHO cells. Results We found that CB1 was able to activate all four subtypes of G proteins, with different pharmacokinetic properties, following stimulation by non-selective (WIN55 and 2-AG) or CB1-selective (ACEA) cannabinoid agonists. Basal activity of CB1 could also be detected with Go and G12 subtypes, as the CB1 inverse agonist AM251 caused significant BRET increase (i.e. G protein subunit association) when tested with these G proteins. In contrast, CB2 showed no G protein activation other than Go, upon either WIN55 or 2-AG stimuli. Stimulation of GPR55 with WIN55, 2-AG or AM251 did not alter the activity of the tested G proteins even at considerably high ligand concentrations.

          Related collections

          Author and article information

          Conference
          BMC Pharmacol
          BMC Pharmacology
          BioMed Central
          1471-2210
          2009
          12 November 2009
          : 9
          : Suppl 2
          : A43
          Affiliations
          [1 ]Department of Physiology, Semmelweis University, Faculty of Medicine, 1082 Budapest, Hungary
          Article
          1471-2210-9-S2-A43
          10.1186/1471-2210-9-S2-A43
          2778915
          2bac4320-5e13-4dc6-be0d-a7d8344cfd2f
          Copyright ©2009 Gyombolai et al; licensee BioMed Central Ltd.
          15th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Joint meeting with the Hungarian Society of Experimental and Clinical Pharmacology (MFT) and the Slovenian Pharmacological Society (SDF)
          Graz, Austria
          19–21 November 2009
          History
          Categories
          Meeting Abstract

          Pharmacology & Pharmaceutical medicine
          Pharmacology & Pharmaceutical medicine

          Comments

          Comment on this article